NEW YORK (GenomeWeb News) - PerkinElmer has agreed to buy ViaCell, a Cambridge, Mass.-based specialty stem cell company, for around $300 million, the companies said Monday.
 
ViaCell focuses on collecting and preserving umbilical cord blood stem cells, and Perkin Elmer said it expects the acquisition to “significantly expand” its neonatal and prenatal screening business.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.